Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial

Drug Research - Germany
doi 10.1055/s-0043-100019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Effect of Aerobic Exercise and Diet on Liver Fat in Pre-Diabetic Patients With Non-Alcoholic-Fatty-Liver-Disease: A Randomized Controlled Trial

Scientific Reports
Multidisciplinary
2017English

Randomised Clinical Trial: The Efficacy and Safety of Oltipraz, a Liver X Receptor Alpha-Inhibitory Dithiolethione in Patients With Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

The Effects of Ezetimibe on Non-Alcoholic Fatty Liver Disease and Glucose Metabolism: A Randomised Controlled Trial

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Randomized Trial Comparing the Effects of Gliclazide, Liraglutide, and Metformin on Diabetes With Non-Alcoholic Fatty Liver Disease

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2017English

Headway and Hurdles in Non-Alcoholic Fatty Liver Disease

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2020English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy